» Articles » PMID: 26241917

Strategies of Polymeric Nanoparticles for Enhanced Internalization in Cancer Therapy

Overview
Publisher Elsevier
Specialty Chemistry
Date 2015 Aug 5
PMID 26241917
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

In order to achieve long circulation time and high drug accumulation in the tumor sites via the EPR effects, anticancer drugs have to be protected by non-fouling polymers such as poly(ethylene glycol) (PEG), poly(ethylene oxide) (PEO), dextran, and poly(acrylic acid) (PAA). However, the dense layer of stealth polymer also prohibits efficient uptake of anticancer drugs by target cancer cells. For cancer therapy, it is often more desirable to accomplish rapid cellular uptake after anticancer drugs arriving at the pathological site, which could on one hand maximize the therapeutic efficacy and on the other hand reduce probability of drug resistance in cells. In this review, special attention will be focused on the recent potential strategies that can enable drug-loaded polymeric nanoparticles to rapidly recognize cancer cells, leading to enhanced internalization.

Citing Articles

Nanotechnology and nanobots unleashed: pioneering a new era in gynecological cancer management - a comprehensive review.

Kumar N, Mangla M Cancer Chemother Pharmacol. 2025; 95(1):18.

PMID: 39754614 DOI: 10.1007/s00280-024-04747-4.


Recent developments in cancer diagnosis and treatment using nanotechnology.

Ouled Ltaief O, Ben Amor I, Hemmami H, Hamza W, Zeghoud S, Ben Amor A Ann Med Surg (Lond). 2024; 86(8):4541-4554.

PMID: 39118776 PMC: 11305775. DOI: 10.1097/MS9.0000000000002271.


Exploring the Therapeutic Potential of Flavonoids in the Management of Cancer.

Singh S, Verma R Curr Pharm Biotechnol. 2024; 26(1):17-47.

PMID: 38591206 DOI: 10.2174/0113892010297456240327062614.


Development and pharmaceutical investigation of novel cervical cancer-targeting and redox-responsive melittin conjugates.

Sahsuvar S, Guner R, Gok O, Can O Sci Rep. 2023; 13(1):18225.

PMID: 37880286 PMC: 10600185. DOI: 10.1038/s41598-023-45537-x.


Innovative Design of Targeted Nanoparticles: Polymer-Drug Conjugates for Enhanced Cancer Therapy.

Junyaprasert V, Thummarati P Pharmaceutics. 2023; 15(9).

PMID: 37765185 PMC: 10537251. DOI: 10.3390/pharmaceutics15092216.